On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Jenacell GmbH's own share of each project, not the project's full budget.
- Horizon 2020€739k · 4 projects
Projects
4 EU-funded projects, newest first. Each links to the official record.
- CARTHAGOPartner
Cartilaginous tissue regeneration by non-viral gene therapy; taking the hurdles towards efficient delivery
Horizon 2020 · 2020–2024 · Project on CORDIS ↗
€253ktheir share - €129ktheir share
- CANCERPartner
Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
€108ktheir share - ISPICPartner
Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome
Horizon 2020 · 2016–2019 · Project on CORDIS ↗
€249ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Percuros BVNetherlands · 4 shared projects
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 3 shared projects
- Tecobiosciences GmbHGermany · 3 shared projects
- Technische Universiteit DelftNetherlands · 2 shared projects
- Universiteit van AmsterdamNetherlands · 2 shared projects
- Universiteit MaastrichtNetherlands · 2 shared projects
- The University of SheffieldUnited Kingdom · 2 shared projects
- Academisch Ziekenhuis LeidenNetherlands · 2 shared projects
- Uniwersytet JagiellonskiPoland · 2 shared projects
- Universita Degli Studi di CamerinoItaly · 2 shared projects
- Universitatea de Medicina Si Farmacie Iuliu Hatieganu Cluj-NapocaRomania · 2 shared projects
- Medres-Medical Research GmbHGermany · 2 shared projects
- Progredum GmbHGermany · 2 shared projects
- Associazione Hand In HandItaly · 2 shared projects
- Consiglio Nazionale Delle RicercheItaly · 1 shared project
- Ecole Polytechnique Federale de LausanneSwitzerland · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- RNA
- biomolecules
- cell biology
- entrepreneurship
- epigenetics
- gene therapy
- immunotherapy
- molecular biology
- nanomedicine
- nucleic acids
- oncology
- personalized medicine
- surgery
- ultrasound
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.